Open Access · CC BY-NC 3.0
Targeting HER-2 in gastric cancer – incorporation of trastuzumab into the treatment of operable disease
Gastrointestinal Cancer: Targets and Therapy · 2011
DOI: 10.2147/gictt.s18495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastrointestinal Cancer: Targets and Therapy, 2011. Verfasst von David Cunningham und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cunningham, D., Okines, A., & Cunningham, D. (2011). Targeting HER-2 in gastric cancer – incorporation of trastuzumab into the treatment of operable disease. Gastrointestinal Cancer: Targets and Therapy. https://doi.org/10.2147/gictt.s18495
Vancouver
Cunningham D, Okines A, Cunningham D. Targeting HER-2 in gastric cancer – incorporation of trastuzumab into the treatment of operable disease. Gastrointestinal Cancer: Targets and Therapy. 2011. doi:10.2147/gictt.s18495
BibTeX
@article{Cunningham2011,
author = {Cunningham, David and Okines, Alicia and Cunningham, David},
title = {Targeting HER-2 in gastric cancer – incorporation of trastuzumab into the treatment of operable disease},
journal = {Gastrointestinal Cancer: Targets and Therapy},
year = {2011},
doi = {10.2147/gictt.s18495}
}
EUVIMED